Also family members living under the same roof have registered for vaccination.
Petaling Jaya, 14 August 2021 – Masmedea Publishing who is the parent company to automotive reviews and news website www.dsf.my is happy to share news that all its employees and the management have already taken their second vaccination against COVID-19.
This good news comes as the company’s management moved swiftly to achieve herd immunity in its daily operations.
We would like to thank the Ministry of Health (MOH) for their guidance and assistance in ensuring all our staff who registered on MySejahtera had been given the vaccine as quickly as possible.
“We are able to hit the ground running to continue reviewing cars and attending new car launches and meetings once the Malaysian automotive industry is given the green-light to resume operations nationwide which is expected to be in the next week or so,” said Daniel Fernandez, Managing Editor and Founder of www.dsf.my.
We thank all our partners in the industry and look forward to resuming to as normal as possible working conditions.
The Importance of COVID-19 vaccination
The COVID-19 vaccines produce protection against the disease, as a result of developing an immune response to the SARS-Cov-2 virus. Developing immunity through vaccination means there is a reduced risk of developing the illness and its consequences.
This immunity helps you fight the virus if exposed. Getting vaccinated may also protect people around you, because if you are protected from getting infected and from disease, you are less likely to infect someone else.
This is particularly important to protect people at increased risk for severe illness from COVID-19, such as healthcare providers, older or elderly adults, and people with other medical conditions.
Scientists around the world are developing many potential vaccines for COVID-19. These vaccines are all designed to teach the body’s immune system to safely recognize and block the virus that causes COVID-19.
Several different types of potential vaccines for COVID-19 are in development, including:
- Inactivated or weakened virus vaccines, which use a form of the virus that has been inactivated or weakened so it doesn’t cause disease, but still generates an immune response.
- Protein-based vaccines, which use harmless fragments of proteins or protein shells that mimic the COVID-19 virus to safely generate an immune response.
- Viral vector vaccines, which use a safe virus that cannot cause disease but serves as a platform to produce coronavirus proteins to generate an immune response.
- RNA and DNA vaccines, a cutting-edge approach that uses genetically engineered RNA or DNA to generate a protein that itself safely prompts an immune response.
